Literature DB >> 6995092

Use of levamisole in cancer patients.

F Spreafico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6995092     DOI： 10.2165/00003495-198020020-00003

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  16 in total

Review 1.  Levamisole in the modulation of the immune response: the current experimental and clinical state.

Authors:  J Symoens; M Rosenthal
Journal:  J Reticuloendothel Soc       Date:  1977-03

2.  Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.

Authors:  H J Wanebo; E Y Hilal; C M Pinsky; E W Strong; V Mike; Y Hirshaut; H F Oettgen
Journal:  Cancer Treat Rep       Date:  1978-11

3.  Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.

Authors:  R L Gonzalez; L E Spitler; R W Sagebiel
Journal:  Cancer Treat Rep       Date:  1978-11

4.  Letter: Levamisole and bone-marrow restoration after chemotherapy.

Authors:  J C Lods; P Dujardin; G M Halpern
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

5.  Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.

Authors:  H M Anthony; A J Mearns; M K Mason; D G Scott; K Moghissi; P B Deverall; Z J Rozycki; D A Watson
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

6.  Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.

Authors:  E J Stephens; H F Wood; B Mason
Journal:  Recent Results Cancer Res       Date:  1978

7.  Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data.

Authors:  W K Amery; F Spreafico; A F Rojas; E Denissen; M Chirigos
Journal:  Cancer Treat Rev       Date:  1977-09       Impact factor: 12.111

8.  Actinomycin-D, levamisole chemoimmunotherapy of refractory malignant melanoma.

Authors:  S W Hall; R S Benjamin; U Lewinski; G Mavligit
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

9.  Cancer immunotherapy with levamisole.

Authors:  H Miwa; K Orita
Journal:  Acta Med Okayama       Date:  1978-07       Impact factor: 0.892

10.  Immunocompetence of cancer patients treated with Levamisole.

Authors:  S A Wilkins; Z L Olkowski
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860
View more
  1 in total

Review 1.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.